Therapeutic Advances in Medical Oncology

Published by: Sage Publications Ltd.  

People

  1. Jhaveri
    Jhaveri
  2. Dang
    Dang
  3. Goldfarb
    Goldfarb
  4. Hudis
    Hudis
  5. Ilson
    Ilson
  6. Modi
    Modi
  7. Razavi
    Razavi
  8. Saltz
    Saltz
  9. Voss
    Voss

Groups

  1. Department of Medicine (10)
  2. Solid Tumor Oncology Division (10)
  3. Breast Medicine Service (6)
  4. Gastrointestinal Oncology Service (2)
  5. Genitourinary Oncology Service (2)
  6. Survivorship Research (2)
  7. Epidemiology and Biostatistics (1)
  8. Health Outcomes Research Group (1)
  9. Population Sciences Research Program (1)
Search Within
  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (5)
  2. Review (5)
Groups
  1. Department of Medicine (10)
  2. Solid Tumor Oncology Division (10)
  3. Breast Medicine Service (6)
  4. Gastrointestinal Oncology Service (2)
  5. Genitourinary Oncology Service (2)
  6. Survivorship Research (2)

More Groups

People
  1. Komal Jhaveri (2)
  2. Chau Dang (1)
  3. Chung-Han Lee (1)
  4. Clifford Hudis (1)
  5. David Ilson (1)
  6. Derek Power (1)

More People

Years
  1. 2023 (4)
  2. 2022 (1)
  3. 2021 (3)
  4. 2011 (1)
  5. 2009 (1)
Publishers
  1. Sage Publications Ltd. (10)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Matching-adjusted indirect comparison of PFS and OS comparing ribociclib plus letrozole versus palbociclib plus letrozole as first-line treatment of HR+/HER2− advanced breast cancer
    Journal Article

    Jhaveri, K.; O’Shaughnessy, J.; Fasching, P. A.; Tolaney, S. M.; Yardley, D. A.; Sharma, V. K.; Biswas, C.; Thuerigen, A.; Pathak, P.; Rugo, H. S.
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • Evolving perspectives on the treatment of HR+/HER2+ metastatic breast cancer
    Review

    Pegram, M.; Pietras, R.; Dang, C. T.; Murthy, R.; Bachelot, T.; Janni, W.; Sharma, P.; Hamilton, E.; Saura, C.
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • Targeting HER2-low in metastatic breast cancer: An evolving treatment paradigm
    Review

    Yang, C.; Brezden-Masley, C.; Joy, A. A.; Sehdev, S.; Modi, S.; Simmons, C.; Henning, J. W.
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • Quality of life with ribociclib versus abemaciclib as first-line treatment of HR+/HER2− advanced breast cancer: A matching-adjusted indirect comparison
    Journal Article

    Rugo, H. S.; Harmer, V.; O’Shaughnessy, J.; Jhaveri, K.; Tolaney, S. M.; Cardoso, F.; Bardia, A.; Maheshwari, V. K.; Tripathi, S.; Haftchenary, S.; more...
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: Current and emerging role
    Review

    Lloyd, M. R.; Wander, S. A.; Hamilton, E.; Razavi, P.; Bardia, A.
    Therapeutic Advances in Medical Oncology (2022)

    Fulltext@MSK | Save
  • Novel emerging biomarkers to immunotherapy in kidney cancer
    Review

    Ged, Y.; Voss, M. H.
    Therapeutic Advances in Medical Oncology (2021)

    Fulltext@MSK | Save
  • New approaches to first-line treatment of advanced renal cell carcinoma
    Review

    George, D. J.; Lee, C. H.; Heng, D.
    Therapeutic Advances in Medical Oncology (2021)

    Fulltext@MSK | Save
  • Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: An ARCAD database analysis
    Journal Article

    Yin, J.; Dawood, S.; Cohen, R.; Meyers, J.; Zalcberg, J.; Yoshino, T.; Seymour, M.; Maughan, T.; Saltz, L.; Van Cutsem, E.; more...
    Therapeutic Advances in Medical Oncology (2021)

    Fulltext@MSK | Save
  • Bevacizumab in metastatic breast cancer: When may it be used?
    Journal Article

    Goldfarb, S. B.; Hudis, C.; Dickler, M. N.
    Therapeutic Advances in Medical Oncology (2011)

    Fulltext@MSK | Save
  • Integration of targeted agents in the neo-adjuvant treatment of gastro-esophageal cancers
    Journal Article

    Power, D. G.; Ilson, D. H.
    Therapeutic Advances in Medical Oncology (2009)

    Fulltext@MSK | Save

    • Therapeutic Advances in Medical Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    Therapeutic Advances in Medical Oncology 17588340 The Author(s), 2016
    Therapeutic Advances in Medical Oncology 17588340 The Author(s), 2022
    Therapeutic Advances in Medical Oncology 1758-8340 Sage Publications Ltd.
    Therapeutic Advances in Medical Oncology 17588340 The Author(s), 2023
    Therapeutic Advances in Medical Oncology 17588340 Sage Publications
    Therapeutic Advances in Medical Oncology 17588340 The Author(s), 2018
    Therapeutic Advances in Medical Oncology 17588340 Sage Publications
    Therapeutic Advances in Medical Oncology 17588340 The Author(s), 2021
    Therapeutic Advances in Medical Oncology 1758-8340 Sage Publications
    Therapeutic Advances in Medical Oncology 1758-8340 Sage Publications